Dalia T Kamal

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The present study aims to identify predictors for response to combination therapy with pioglitazone plus exenatide vs basal/bolus insulin therapy in T2DM patients who are poorly controlled with(More)
  • 1